U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 710

1.
The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate
Nitza Lahat, Beny Alexander, Richter Dan Levin, Boaz Moskovitz
Cancer Immunol Immunother. 1989 Mar; 28(3): 208–212. doi: 10.1007/BF00204990
PMCID:
PMC11038801
ArticlePDF–470K
2.
Mucinous Adenocarcinoma of the Prostate With Normal Prostate-Specific Antigen Levels, Pulmonary Metastasis, and the Absence of Nodal Disease: A Case Report
Arham A Khokhar, Sarah A Howles, Aaron W Leiblich, Khubaib Samdani, Mubariz Ahmed
Cureus. 2024 Mar; 16(3): e56563. Published online 2024 Mar 20. doi: 10.7759/cureus.56563
PMCID:
PMC11029818
ArticlePDF–1.4M
3.
High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma
Roya Ghods, Mohammad-Hossein Ghahremani, Zahra Madjd, Mojgan Asgari, Maryam Abolhasani, Sanaz Tavasoli, Ahmad-Reza Mahmoudi, Maryam Darzi, Parvin Pasalar, Mahmood Jeddi-Tehrani, Amir-Hassan Zarnani
Cancer Immunol Immunother. 2014 Dec; 63(12): 1319–1327. Published online 2014 Sep 4. doi: 10.1007/s00262-014-1594-z
PMCID:
PMC11029513
ArticlePDF–927K
4.
Overexpression of Fibroblast Activation Protein (FAP) in stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate
Fernanda Caramella-Pereira, Qizhi Zheng, Jessica L. Hicks, Sujayita Roy, Tracy Jones, Martin Pomper, Lizamma Antony, Alan K. Meeker, Srinivasan Yegnasubramanian, Angelo M. De Marzo, W. Nathaniel Brennen
Version 1. medRxiv. Preprint. 2024 Apr 5. doi: 10.1101/2024.04.04.24305338
PMCID:
PMC11023661
Article
5.
Concomitant Bilateral Inferior Gluteal Lymph Node Involvement in Metastatic Prostate Adenocarcinoma Detected on 68 Gallium-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography
Parth Baberwal, Sunita Sonavane, Sandip Basu
World J Nucl Med. 2024 Mar; 23(1): 46–48. Published online 2024 Feb 6. doi: 10.1055/s-0044-1779281
PMCID:
PMC11001436
ArticlePDF–1.4M
6.
Identification of Molecular Subtype and Prognostic Signature for Prostate Adenocarcinoma based on Neutrophil Extracellular Traps
Yanfen Zheng, Hui Sun, Shanshan Yang, Wei Liu, Guanmin Jiang
J Cancer. 2024; 15(9): 2678–2690. Published online 2024 Mar 17. doi: 10.7150/jca.93275
PMCID:
PMC10988314
ArticlePDF–7.0M
7.
Post-therapeutic squamous cell transformation of a metastatic prostate adenocarcinoma with comparison of molecular profiles: a case report and review of the literature
Peizi Li, George K Haines, Qiusheng Si, Brett Baskovich
Int J Clin Exp Pathol. 2024; 17(3): 78–82. Published online 2024 Mar 15. doi: 10.62347/ZQCI9925
PMCID:
PMC10988092
ArticlePDF–212K
8.
An androgen receptor-based signature to predict prognosis and identification of ORC1 as a therapeutical target for prostate adenocarcinoma
Linjin Li, Dake Chen, Xiang Chen, Jianlong Zhu, Wenshuo Bao, Chengpeng Li, Feilong Miao, Rui Feng
PeerJ. 2024; 12: e16850. Published online 2024 Mar 29. doi: 10.7717/peerj.16850
PMCID:
PMC10984180
ArticlePDF–7.6M
9.
Comprehensive 3DCRT Hypofractionated Radiotherapy Schedule for Localized Prostate Adenocarcinoma in the Era of IMRT: Dosimetric and Endoscopic Analysis
Andromachi Kougioumtzopoulou, Nick Syrigos, Anna Zygogianni, Ioannis Georgakopoulos, Kalliopi Platoni, George Patatoukas, Kimon Tzannis, Aristotelis Bamias, Nikolaos Kelekis, Vasileios Kouloulias
Cancers (Basel) 2024 Mar; 16(6): 1192. Published online 2024 Mar 18. doi: 10.3390/cancers16061192
PMCID:
PMC10969325
ArticlePDF–4.5M
10.
Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing
Alexandra Zara Rozalen, Jose Manuel Martin, Rithika Rajendran, Maneesh Jain, Victor E. Nava
Curr Oncol. 2024 Mar; 31(3): 1556–1561. Published online 2024 Mar 19. doi: 10.3390/curroncol31030118
PMCID:
PMC10968787
ArticlePDF–1.8M
11.
Testicular metastasis of prostate adenocarcinoma: the other side of orchiepididymitis
Gianluca Di Rienzo, Alessandro Tafuni, Umberto Maestroni, Livia Ruffini, Enrico Maria Silini, Donatello Gasparro, Francesco Paolo Pilato, Letizia Gnetti
Pathologica. 2024 Feb; 116(1): 69–74. Published online 2024 Mar 1. doi: 10.32074/1591-951X-940
PMCID:
PMC10938275
ArticlePDF–710K
12.
Acute onset of Lambert Eaton myasthenic syndrome in prostate adenocarcinoma: a case report
Nicu Cătălin Drăghici, Elena Olariu, Tudor Dimitrie Lupescu, Fior Dafin Mureşanu
Med Pharm Rep. 2024 Jan; 97(1): 95–98. Published online 2024 Jan 29. doi: 10.15386/mpr-2541
PMCID:
PMC10852129
ArticlePDF–1.6M
13.
Case report: Robotically visualized and biopsy-confirmed peritoneal carcinomatosis as initial identification of metastatic prostate adenocarcinoma in a patient with a history of prostatic urethral lift
Qateeb Khan, Bryn Myers, Breann Bowar, Maryam Khan, Henry Mullaney, Jordan Gainey, Robert Schneider, Laila Dahmoush, Kenneth G. Nepple, James D. Byrne
Front Oncol. 2023; 13: 1284688. Published online 2024 Jan 19. doi: 10.3389/fonc.2023.1284688
PMCID:
PMC10834618
ArticlePDF–2.6M
14.
Long-Term Survival After Definitive Concurrent Chemoradiation Therapy for Synchronous Small Cell Neuroendocrine Carcinoma of the Urinary Bladder and Adenocarcinoma of the Prostate: A Case Report
Michael T Hsieh, Richard Tustin, Tue Le, Abdul Rahim Mohd Tahir, Thomas P Shakespeare
Cureus. 2024 Jan; 16(1): e51481. Published online 2024 Jan 1. doi: 10.7759/cureus.51481
PMCID:
PMC10830151
ArticlePDF–1.6M
15.
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma
Alex Stanley Balraj, Sangeetha Muthamilselvan, Rachanaa Raja, Ashok Palaniappan
Technol Cancer Res Treat. 2024; 23: 15330338231222389. Published online 2024 Jan 16. doi: 10.1177/15330338231222389
Correction in:
Technol Cancer Res Treat. 2024; 23: 15330338241237334.
PMCID:
PMC10793196
ArticlePDF–4.0M
16.
Construction and validation of a prognostic nomogram for ductal adenocarcinoma of the prostate: A population-based study
Cheng Li, Zhengqiang Wan, Yinglei Wang, Guangming Shan, Baoquan Yang
Medicine (Baltimore) 2024 Jan 12; 103(2): e36877. Published online 2024 Jan 12. doi: 10.1097/MD.0000000000036877
PMCID:
PMC10783338
ArticlePDF–1.3M
17.
Binary semantic segmentation for detection of prostate adenocarcinoma using an ensemble with attention and residual U-Net architectures
Kasikrit Damkliang, Paramee Thongsuksai, Kanita Kayasut, Thakerng Wongsirichot, Chanwit Jitsuwan, Tarathep Boonpipat
PeerJ Comput Sci. 2023; 9: e1767. Published online 2023 Dec 20. doi: 10.7717/peerj-cs.1767
PMCID:
PMC10773872
ArticlePDF–34M
18.
Mucin‐producing urothelial‐type adenocarcinoma of the prostate with sarcomatoid features and novel molecular phenotype
Pranav S Renavikar, Thomas J Auen, David G Wagner, Subodh M Lele
IJU Case Rep. 2024 Jan; 7(1): 77–82. Published online 2023 Nov 20. doi: 10.1002/iju5.12672
PMCID:
PMC10758892
ArticlePDF–6.0M
19.
Integrated analysis of the potential roles of microRNA-messenger RNA networks in prostate adenocarcinoma
Ning-bo Zhang, Jian-jiang Jin, Xing-hong Ye
Heliyon. 2023 Dec; 9(12): e22383. Published online 2023 Nov 17. doi: 10.1016/j.heliyon.2023.e22383
PMCID:
PMC10709018
ArticlePDF–16M
20.
Primary synovial sarcoma and acinar adenocarcinoma of prostate rarely occur simultaneously: A case report
Qichong Shi, Yun Zhou, Longmei Wang
Medicine (Baltimore) 2023 Nov 24; 102(47): e36151. Published online 2023 Nov 24. doi: 10.1097/MD.0000000000036151
PMCID:
PMC10681603
ArticlePDF–732K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center